Beurs gesloten -
Japan Exchange
08:00:00 02-05-2024
|
Variatie 5 dagen
|
Verschil t.o.v. 1 jan (%)
|
49
JPY
|
0,00%
|
|
0,00%
|
-31,94%
|
Fiscaal tijdperk: december |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Marktkapitalisatie
1 |
35.197
|
68.353
|
165.659
|
58.780
|
20.914
|
14.229
|
Bedrijfswaarde
1 |
29.413
|
58.313
|
154.122
|
40.881
|
11.033
|
10.430
|
K/w-verhouding
|
-10,5
x
|
-17,8
x
|
-35,2
x
|
-4,14
x
|
-1,29
x
|
-1,83
x
|
Dividendrendement
|
-
|
-
|
-
|
-
|
-
|
-
|
Marktkapitalisatie/omzet
|
57,7
x
|
210
x
|
4.248
x
|
918
x
|
312
x
|
93,6
x
|
Bedrijfswaarde/omzet
|
48,2
x
|
179
x
|
3.952
x
|
639
x
|
165
x
|
68,6
x
|
Bedrijfswaarde/EBITDA
|
-9,62
x
|
-17,9
x
|
-27,6
x
|
-3,1
x
|
-0,82
x
|
-1,18
x
|
Bedrijfswaarde/FCF
|
-20,2
x
|
-53,8
x
|
-1.382
x
|
-5,69
x
|
-2,11
x
|
-1,14
x
|
FCF Yield
|
-4,95%
|
-1,86%
|
-0,07%
|
-17,6%
|
-47,3%
|
-88%
|
Price to Book
|
4,6
x
|
5,67
x
|
5,07
x
|
1,52
x
|
0,72
x
|
0,55
x
|
Aantal aandelen (in duizenden)
|
96.961
|
106.969
|
133.059
|
153.072
|
171.424
|
197.620
|
Referentieprijs
2 |
363,0
|
639,0
|
1.245
|
384,0
|
122,0
|
72,00
|
Datum van publicatie
|
29-03-19
|
30-03-20
|
31-03-21
|
31-03-22
|
31-03-23
|
29-03-24
|
Fiscaal tijdperk: december |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Omzet
1 |
610
|
326
|
39
|
64
|
67
|
152
|
EBITDA
1 |
-3.058
|
-3.263
|
-5.593
|
-13.207
|
-13.415
|
-8.860
|
Bedrijfsresultaat (EBIT)
1 |
-3.065
|
-3.270
|
-5.600
|
-15.632
|
-16.316
|
-11.968
|
Operationele Marge
|
-502,46%
|
-1.003,07%
|
-14.358,97%
|
-24.425%
|
-24.352,24%
|
-7.873,68%
|
Resultaat voor belastingen (EBT)
1 |
-3.002
|
-3.750
|
-4.205
|
-13.734
|
-14.716
|
-7.470
|
Nettowinst (verlies)
1 |
-2.996
|
-3.750
|
-4.209
|
-13.675
|
-14.714
|
-7.437
|
Nettomarge
|
-491,15%
|
-1.150,31%
|
-10.792,31%
|
-21.367,19%
|
-21.961,19%
|
-4.892,76%
|
WPA
2 |
-34,45
|
-35,81
|
-35,32
|
-92,85
|
-94,29
|
-39,29
|
Free Cash Flow
1 |
-1.457
|
-1.085
|
-111,5
|
-7.179
|
-5.220
|
-9.178
|
FCF-marge
|
-238,79%
|
-332,75%
|
-285,9%
|
-11.217,19%
|
-7.790,3%
|
-6.038,16%
|
Kasstroomconversie (ebitda)
|
-
|
-
|
-
|
-
|
-
|
-
|
Kasstroomconversie (nettowinst)
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per aandeel
|
-
|
-
|
-
|
-
|
-
|
-
|
Datum van publicatie
|
29-03-19
|
30-03-20
|
31-03-21
|
31-03-22
|
31-03-23
|
29-03-24
|
Fiscaal tijdperk: december |
2020 S1
|
2021 S1
|
2021 Q3
|
2022 Q1
|
2022 S1
|
2022 Q3
|
2023 Q1
|
2023 S1
|
2023 Q3
|
---|
Omzet
1 |
16
|
23
|
21
|
15
|
31
|
14
|
16
|
51
|
51
|
EBITDA
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Bedrijfsresultaat (EBIT)
1 |
-1.766
|
-7.540
|
-4.623
|
-3.543
|
-9.124
|
-3.331
|
-3.036
|
-5.951
|
-3.256
|
Operationele Marge
|
-11.037,5%
|
-32.782,61%
|
-22.014,29%
|
-23.620%
|
-29.432,26%
|
-23.792,86%
|
-18.975%
|
-11.668,63%
|
-6.384,31%
|
Resultaat voor belastingen (EBT)
1 |
-1.890
|
-7.436
|
-4.518
|
-2.934
|
-7.420
|
-2.753
|
-2.898
|
-4.777
|
55
|
Nettowinst (verlies)
1 |
-1.896
|
-7.450
|
-4.502
|
-2.938
|
-7.425
|
-2.769
|
-2.911
|
-4.830
|
32
|
Nettomarge
|
-11.850%
|
-32.391,3%
|
-21.438,1%
|
-19.586,67%
|
-23.951,61%
|
-19.778,57%
|
-18.193,75%
|
-9.470,59%
|
62,75%
|
WPA
2 |
-16,58
|
-52,70
|
-29,55
|
-19,20
|
-48,51
|
-18,09
|
-15,91
|
-26,09
|
0,4000
|
Dividend per aandeel
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Datum van publicatie
|
30-07-20
|
06-08-21
|
05-11-21
|
10-05-22
|
09-08-22
|
08-11-22
|
10-05-23
|
09-08-23
|
08-11-23
|
Fiscaal tijdperk: december |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Nettoschuldpositie
1 |
-
|
-
|
-
|
-
|
-
|
-
|
Nettokaspositie
1 |
5.784
|
10.040
|
11.537
|
17.899
|
9.881
|
3.799
|
Hefboom (schuld/ebitda)
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
-1.457
|
-1.085
|
-112
|
-7.179
|
-5.220
|
-9.178
|
ROE (netto-inkomsten/eigen vermogen)
|
-52,8%
|
-37,9%
|
-18,8%
|
-38,4%
|
-42,6%
|
-26,3%
|
ROA (netto-inkomsten/totale activa)
|
-31,9%
|
-19,9%
|
-13,8%
|
-23,3%
|
-24,2%
|
-22,1%
|
Totale activa
1 |
9.394
|
18.875
|
30.592
|
58.653
|
60.800
|
33.661
|
Nettoactief per aandeel
2 |
78,90
|
113,0
|
246,0
|
252,0
|
170,0
|
132,0
|
Cashflow per aandeel
2 |
59,00
|
93,90
|
86,70
|
117,0
|
61,80
|
21,00
|
Capex
1 |
50
|
6
|
80
|
80
|
19
|
89
|
Capex/omzet
|
8,2%
|
1,84%
|
205,13%
|
125%
|
28,36%
|
58,55%
|
Datum van publicatie
|
29-03-19
|
30-03-20
|
31-03-21
|
31-03-22
|
31-03-23
|
29-03-24
|
|
Vaira. 1 jan.
|
Kapi.
|
---|
| -31,94% | 64,13 mln. | | -1,43% | 103 mld. | | +8,96% | 101 mld. | | +4,40% | 23,07 mld. | | -12,15% | 22,23 mld. | | -4,36% | 18,05 mld. | | -39,98% | 17,18 mld. | | -10,04% | 16,94 mld. | | +6,79% | 14,07 mld. | | +38,61% | 12,35 mld. |
Biotherapeutische geneesmiddelen
|